Compare APRE & XPON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | APRE | XPON |
|---|---|---|
| Founded | 2006 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Electronic Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.4M | 7.8M |
| IPO Year | 2019 | 2022 |
| Metric | APRE | XPON |
|---|---|---|
| Price | $0.72 | $0.60 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $4.10 | N/A |
| AVG Volume (30 Days) | ★ 216.2K | 206.1K |
| Earning Date | 05-13-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 21.22 | ★ 94.63 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $9,651,870.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 71.59 |
| 52 Week Low | $0.55 | $0.49 |
| 52 Week High | $2.22 | $5.50 |
| Indicator | APRE | XPON |
|---|---|---|
| Relative Strength Index (RSI) | 45.75 | 44.32 |
| Support Level | $0.55 | N/A |
| Resistance Level | $0.98 | $0.68 |
| Average True Range (ATR) | 0.07 | 0.06 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 48.08 | 44.80 |
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.
Expion360 Inc is focused on the design, assembly, manufacturing, and sales of lithium iron phosphate (LiFePO4) batteries and supporting accessories for recreational vehicles (RV's) and marine applications with plans to expand into home energy storage products and industrial applications. Its product offerings include some of the minimal-footprint batteries in the RV & Marine industry.